Man Group PLC National Research Corp Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$36.87 - $41.2 $662,443 - $740,240	-17,967 Reduced 75.84%	5,725 $226,000
Q4 2023 Feb 14, 2024	BUY	$39.05 - $46.39 $413,929 - $491,734	10,600 Added 80.97%	23,692 $937,000
Q3 2023 Nov 14, 2023	BUY	$41.8 - $46.78 $547,245 - $612,443	13,092 New	13,092 $580,000
Q1 2023 May 15, 2023	BUY	$38.17 - $47.17 $22,902 - $28,302	600 Added 8.83%	7,392 $321,000
Q4 2022 Feb 14, 2023	BUY	$35.23 - $41.21 $3,522 - $4,121	100 Added 1.49%	6,792 $253,000
Q2 2022 Aug 15, 2022	BUY	$31.87 - $40.9 $28,683 - $36,810	900 Added 15.54%	6,692 $256,000
Q1 2022 May 16, 2022	BUY	$36.33 - $42.25 $25,431 - $29,575	700 Added 13.75%	5,792 $230,000
Q4 2021 Feb 14, 2022	BUY	$40.05 - $49.0 $203,934 - $249,508	5,092 New	5,092 $211,000

145

12.7M

300

300

Ticker NRC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 24,767,100
Market Cap $434M
Description
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.